Year: 2019| BMJ EBM Spotlight
In 2020, the UK National Institute for Health and Care Excellence (NICE) undertook two systematic evidence reviews of the use of GnRH agonists (also known as "puberty blockers") and cross-sex hormones as treatments for gender dysphoric patients| segm.org
The Tavistock puberty blockers experiment began in 2010. Over 1,000 adolescents have now been treated. Where is the evidence blockers are safe & effective?| Transgender Trend
How Caring People Become Cheerleaders for Hurting Children| caroldansereau.substack.com